Open Access

Major parasitic diseases of poverty in mainland China: perspectives for better control

Contributed equally
Infectious Diseases of Poverty20165:67

https://doi.org/10.1186/s40249-016-0159-0

Received: 6 February 2016

Accepted: 20 June 2016

Published: 1 August 2016

Abstract

Significant progress has been made in the prevention, control, and elimination of human parasitic diseases in China in the past 60 years. However, parasitic diseases of poverty remain major causes of morbidity and mortality, and inflict enormous economic costs on societies.

In this article, we review the prevalence rates, geographical distributions, epidemic characteristics, risk factors, and clinical manifestations of parasitic diseases of poverty listed in the first issue of the journal Infectious Diseases of Poverty on 25 October 2012. We also address the challenges facing control of parasitic diseases of poverty and provide suggestions for better control.

Keywords

ChinaPovertyParasitic diseases of povertyEpidemic characteristicsPreventionControlElimination

Multilingual abstracts

Please see Additional file 1 for translations of the abstract into the six official working languages of the United Nations.

Background

Infectious diseases of poverty (IDoPs) are a series of diseases closely related to poverty, which are mainly prevalent in the least developed countries and regions of the world [13]. Most IDoPs are neglected tropical diseases, causing disabling chronic infections, and even death [2]. In addition, IDoPs can result in huge economic losses and make it more difficult for poor people to improve their quality of life and social status [3].

It has been estimated that IDoPs affect three billion people worldwide, and they kill almost nine million people each year, many of them are children under five [3]. Factors such as climate change and population migration have accelerated the spread of these diseases, causing health and socioeconomic problems globally. It is a vicious cycle: poverty due to endemic IDoPs depresses economies in the affected communities by reducing people’s ability to work. This in turn renders the poor less able to pay for treatment and also aggravates transmission of IDoPs [26].

Although tremendous achievements have been made in fighting IDoPs in China in the past 60 years, the sheer scale of the task means that the country still accounts for a large percentage of the global burden of disease due to IDoPs. For example, schistosomiasis still affects at least a hundred thousand people in China, and up to 90 % of the world’s burden of alveolar echinococcosis is attributed to China, where about 86 million people are at risk [79]. Of the 15 million people who are infected with Clonorchis sinensis globally, over 85 % live in China [79].

In this review, our main objectives are to describe the prevalence rates, geographical distributions, epidemic characteristics, risk factors, and clinical manifestations of parasitic diseases of poverty listed in first issue of the journal Infectious Diseases of Poverty on 25 October 2012, which have caused extensive damage in China (see Table 1) [1]. We also discuss the current challenges and strategies for controlling these diseases.
Table 1

Key characteristics of parasitic diseases of poverty in China

Disease

Parasite

Definitive host

Intermediate host

Factors relating to infectiona

Clinical manifestations

DALYsb (thousands)

Vector-borne diseases

 

Malaria [1013]

Plasmodium spp.

Humans and other animals

Mosquito

Children, pregnant women, humble house, lack of bed nets, immigrants from epidemic regions, occupation dependent exposure to mosquitoes

Fever, headache, shock, jaundice, abnormal bleeding, nausea, vomiting, diarrhea, anemia, hepatosplenomegaly

82 685

Leishmaniasis [2628]

Leishmania spp.

Humans and other mammals

Sandfly

Children, the older, males, dog ownership, herdsman, humble house, sleeping outside, occupation dependent exposure to sandfly

CL: Skin papules, plaque, ulcer and nodular prurigo

ML: Edema and erythema on nose, nasal stuffiness or bleeding, mucosal lesions

VL: Fever, weight loss, anemia, hepatosplenomegaly

3 317

Lymphatic filariasis [3133]

Wuchereria bancrofti

Brugia malayi

Brugia timori

Humans

Mosquito

Humble house, lack of bed nets, occupation dependent exposure to mosquitoes

Lymphangitis, lymphnoditis,

lymphoedema, elephantedema hydrocele, chyluria

2 775

Snail-borne diseases

 

Schistosomiasis [3537]

Schistosoma spp.

Humans and other mammals

Oncomelania hupensis

Males, high frequency of water contact, occupation dependent exposure to snails, snails related practices

Fever, headache, abdominal pain, hematuria, anemia, bloody stool, hepatosplenomegaly, colonic tumoroid proliferation, ascites, hydronephrosis, dwarfism, megalosplenia

3 309

Clonorchiasis [4244]

Clonorchis sinensis

Humans and other mammals

Water snails, fish and shrimps

Males, the older, high frequency of eating of raw or undercooked freshwater fish

Inappetence, abdominal pain, gallstone, jaundice, anemia, hepatosplenomegaly, pyogenic cholangitis, cholecystitis

275

Paragonimiasis [54]

Paragonimus spp.

Humans, cats, dogs and other carnivores

Water snails and crustaceans

Children, high frequency of eating of raw or undercooked freshwater crabs

Chronic cough, chest pain, hemoptysis, pleurisy, dyspnea,

abdominal pain, epilepsy

197

Fascioliasis [5759]

Fasciola gigantica

Fasciola hepatica

Humans and other mammals

Water snails

Children, females, high frequency of eating of raw vegetables or untreated water and contact with ruminants

Fever, anemia, hepatic lesions and fibrosis, hepatomegaly, jaundice, cholangitis, cholecystitis

35

Soil-transmitted helminthiasis

 

Ascariasis

Ascaris lumbricoides

Humans

-

Ascariasis and trichuriasis: school-aged children

Hookworm: the older and farmers

Inappetence, undernutrition, abdominal pain, diarrhea, anemia, growth and cognitive deficits

1 315

Trichuriasis

Trichuris trichiura

Humans

-

638

Hookworm [6366]

Ancylostoma duodenale Necator americanus

Humans

-

3 231

Enterobiasis [66, 70, 72]

Enterobius vermicularis

Humans

-

School-aged children, crowded

Inappetence, restlessness, perianal pruritus and discomfort, insomnia, irritability, growth and cognitive deficits

-

Zoonotic diseases

 

Taeniasis/Cysticercosis [73, 74, 76]

Taenia solium

Taenia saginata Taenia asiatica

Humans

Humans, pig and cattle

Pigs related practices, high frequency of eating of raw pork

Headaches, ocular disorders, epilepsy, seizure, neurological symptoms

503

Echinococcosis [7780, 8486]

Echinococcus granulosus

Echinococcus multilocularis

Dogs and wild canids

Humans and other animals

Females, the older, herdsmen slaughter and viscera disposal practices, dog related practices

AE: Tumour-like multi-vesicular

CE: Unilocular fluid-filled bladders

144

Water-borne diseases

 

Cryptosporidiosis [8890]

Cryptosporidium spp.

Humans and other animals

-

Children, immunocompromised individuals, poor water treatment

Diarrhea, growth deficits, malnutrition, weight loss

8 372

Giardiasis [95]

Giardia spp.

Humans and other animals

-

Children, poor water treatment

Diarrhea, malnutrition, growth deficits, weight loss

-

Toxoplasmosis [98101]

Toxoplasma gondii

Felids

Humans and other animals

The older, cancer patients,

immunocompromised individuals,

cat related practices

Blindness, mental deficiency, encephalitis, stillbirths, abortion

-

Outbreak parasitic diseases

     

Angiostrongyliasis [104107]

Angiostrongylus cantonensis

Rats

Snails and slugs

High frequency of eating of raw or undercooked snails

Eosinophilic meningitis,

headache, somnolence,

ocular angiostrongyliasis

-

aPoverty, poor sanitation and inadequate hygiene and poor knowledge of, attitudes towards and practice relating to parasites are also the predisposing factors to these diseases. bSource: WHO, Global Burden of Diseases 2010 [42, 130]

Review

Vector-borne parasitic diseases

Malaria

Malaria, one of the most threatening diseases worldwide, is endemic in over 100 developing countries, with about 58 % of deaths due to malaria occurring in poor communities [1013]. Five species of the genus Plasmodium commonly infect human beings. Plasmodium falciparum and P. vivax cause the majority of infections, with most malaria deaths caused by P. falciparum. Both of these species may cause abortion and intrauterine growth retardation if infection occurs during pregnancy. The species P. ovale, P. malariae, and P. knowlesi can also infect humans but are uncommon, and do not manifest in serious symptoms [1013].

Although significant progress has been made in reducing the malaria burden, there were still 198 million malaria cases worldwide in 2013, causing 584 000 deaths [1416]. In China, malaria, mainly due to P. falciparum and P. vivax can be traced back 4 000 years. Before the foundation of the People’s Republic of China, malaria threatened 75 % of the Chinese population: over 30 million cases were recorded annually with about a 1 % mortality rate. Since 1949, the overall burden of malaria has been markedly reduced and endemic regions have greatly reduced in area (see Table 2) [1722]. However, this ancient disease still represents a serious public health challenge in China, and some new problems are emerging. Before 2012, P. vivax was the major species of malaria parasite in China. Despite the lower mortality caused by this species, it is a major cause of morbidity. After the National Malaria Elimination Programme was launched in 2010, the incidence of locally transmitted P. vivax malaria has declined, but numbers of imported P. vivax and P. falciparum malaria cases have increased significantly due to the large number of migrant workers and travelers coming into China. P. falciparum has become the major imported species of malaria (see Table 2) [1723]. Antimalarial drug-resistant Plasmodium spp. emerged in some endemic areas and global warming has lead to an expansion of the habitats of mosquitoes [24]. These factors are making it more challenging to achieve the goal of eliminating malaria by 2020 throughout the entire country, but with continued efforts and new surveillance-response systems, the goal can be achieved.
Table 2

The characteristics of malaria in China from 2011 to 2014 [1821]

Year

Number of malaria cases

Number of deaths

Annual incidence

The proportion of endemic counties

The proportion of laboratory confirmed cases

The proportion of foreign imported cases

Major malaria endemic province

2011

4 479 (3 658 laboratory confirmed cases and 821 clinically diagnosed cases)

33

0.0334/10 000

27.4 % (782/2 856)

P. falciparum: 40.2 %

P. vivax: 56.7 %

P. ovale or P. malaride: 1.9 %

Mixed infection: 1.1 %

66.4 %

Anhui 40.0 % Yunnan 25.8 % Henan 12.6 % Guizhou 10.4 % Hubei 6.1 %

2012

2 718 (2 599 laboratory confirmed cases and 119 clinically diagnosed cases)

15

0.0202/10 000

21.7 % (620/2 853)

P. falciparum: 54.6 %

P. vivax: 41.6 %

P. ovale or P. malaride: 2.1 % Mixed infection: 1.7 %

91.0 %

Yunnan 31.4 % Guangxi 8.1 % Jiangsu 7.3 % Hunan 5.8 % Sichuan 5.7 %

2013

4 128 (4 087 laboratory confirmed cases and 41 clinically diagnosed cases)

23

0.0305/10 000

21.2 % (605/2 852)

P. falciparum: 71.2 %

P. vivax: 22.8 %

P. ovale or P. malaride: 4.5 %

Mixed infection: 1.6 %

97.9 %

Guangxi 30.3 % Yunnan 14.0 % Jiangsu 8.3 % Sichuan 5.8 %

Zhejiang 5.0 %

2014

3 078 (3 057 laboratory confirmed cases and 21 clinically diagnosed cases)

25

0.0226/10 000

23.8 % (680/2 853)

P. falciparum: 61.6 %

P. vivax: 27.7 %

P. ovale or P. malaride: 9.3 %

Mixed infection: 1.4 %

98.1 %

Yunnan 17.3 %

Jiangsu 11.5 %

Sichuan 8.6 %

Henan 7.0 %

Zhejiang 7.0 %

Leishmaniasis

Leishmaniasis is highly prevalent in poor countries in Southeast Asia, East Africa, and Latin America. The disease is present in 88 countries, resulting in 1.5–2 million new cases each year [25]. The three different forms of leishmaniasis are cutaneous leishmaniasis (CL), mucosal leishmaniasis (ML), and visceral leishmaniasis (VL) [2628]. VL, the most severe form, is caused by Leishmania donovani or L. infantum, and falls into three different epidemiological types in China: the anthroponotic type, the zoonotic mountain type, and the zoonotic desert type [28]. It was once highly prevalent and rampant in areas north and northwest of the Yangtze River, especially in the rural regions of Shandong, Jiangsu, Anhui, and Henan provinces. In 1951, about 530 000 VL cases occurred across more than 650 counties in at least 16 provinces/autonomous regions/municipalities (P/A/Ms) in China. National control programs undertaken in the 1950s aimed at exterminating the sandfly vector, curing infected dogs, and treating patients. Since then, the disease has been effectively controlled and almost eliminated in eastern and northern China. The number of VL cases decreased to 360 in 1990, with some sporadic cases reported in six provinces in the central and western China: Xinjiang Uygur and Inner Mongolia Autonomous Regions, and Gansu, Sichuan, Shaanxi, and Shanxi provinces. However, transmission in these provinces was never completely interrupted and the number of VL cases has increased from 2003 to 2009. The number of areas of transmission has expanded in recent years due to population movement and ecological changes. This might explain the outbreak of VL in Jiashi county, Xinjiang Uygur in 2009 [28, 29]. A total of 3601 cases were officially reported between 2004 and 2014 in China, varying from 158 to 509 cases per year. There was a sharp increase in 2008 and 2009, with an incidence of 0.0169/100 000 in 2009 [30]. More than 97 % of these cases were concentrated in Xinjiang Uygur, Gansu, and Sichuan, where reservoirs of Leishmania and sandfly vectors remain common [30].

Lymphatic filariasis

Lymphatic filariasis is caused by three closely-related filarial nematodes: Wuchereria bancrofti, Brugia malayi, and B. timori. This disease affects more than 120 million people worldwide, about 40 million of them are disabled and disfigured [3133]. Sixty years ago, lymphatic filariasis was widely prevalent in mainland China, with 31 million cases and 330 million people at risk living in 864 endemic counties in 16 P/A/Ms, mainly in southeastern China. Bancroftian filariasis accounted for about two-thirds of these cases (~22 million) and nine million were Brugian filariasis. Since then, excellent control measures have been introduced, including treatment of infected individuals with diethylcarbamazine (DEC) and the distribution of DEC-fortified salt. The latter measure, in particular, has been very effective for the control and treatment of this disease. By 1980, basic elimination of filariasis was achieved in many endemic counties. By 1994, all 864 endemic counties had reached the basic elimination criteria and reduced the microfilaremia rate to below 1 %. After decades of efforts in control and surveillance of filariasis, China became the first developing country to eliminate lymphatic filariasis in 2007, as verified by the World Health Organization [34]. However, there are still about 400 000 chronic cases resulting from past infections in China, and there is threat of imported infection. Therefore, China should strengthen its surveillance-response system for this disease and provide medical care to patients to overcome these challenges [7].

Snail-borne parasitic diseases

Schistosomiasis

Schistosomiasis causes substantial morbidity and mortality, enforcing a cycle of poverty, especially in already poor rural communities. Three major species (Schistosoma japonicum, S. haematobium, and S. mansoni) can infect humans, with at least 230 million people in approximately 76 developing countries being afflicted [35, 36]. In China, schistosomiasis due to S. japonicum, once a widespread serious disease, has been recorded over the past 2 100 years. In the 1950s, S. japonicum was endemic in 12 P/A/Ms, with around 11.6 million people infected and more than 100 million people at risk of infection. It was estimated that over 1.2 million cattle were infected and that suitable habitat for the snail intermediate host (Oncomelania hupensis) covered an area of 14.3 billion square meters. After the foundation of the People’s Republic of China, the government finally comprehended the enormous social and economic losses due to S. japonicum and adopted a series of prevention and control strategies against the disease. These can be separated into three phases. During the first phase (1950s to early 1980s), snail control was the strategy used to limit transmission of schistosomiasis. Environmental modifications and use of molluscicides in snail habitats significantly reduced the prevalence of the disease. In the second phase (mid-1980s to 2003), large-scale chemotherapy and morbidity control were implemented. Assisted by a World Bank loan, the widespread mass administration of praziquantel reduced the number of schistosomiasis cases from about 1 522 100 in 1989 to 865 000 in 1995. During the third phase (2004 until now), an integrated strategy is being used to reduce potential sources of infection. The intention is to prevent the spread of S. japonicum eggs from the feces of cattle and humans to snails. By 2008, the prevalence rate, both in humans and cattle, had decreased to less than 5 % in all endemic counties [3739]. The number of schistosomiasis cases fell from 842 525 in 2004 to 115,614 in 2014. The number of acute cases reduced from 816 in 2004 to two in 2014, and the extent of suitable habitat for O. hupensis snails was reduced from 7 billion square meters in 2004 to 3.64 billion square meters in 2014 [40, 41]. Some P/A/Ms, including Guangxi Zhuang Autonomous Region and Shanghai, Zhejiang, Guangdong, and Fujian provinces, have now achieved the national criteria for elimination. However, schistosomiasis is still endemic in Anhui, Jiangxi, Hunan, Sichuan, and Yunnan provinces. Factors including global warning and population movements have the potential to cause the reemergence of schistosomiasis [40, 41]. Challenges such as lack of effective tools for snail control, and the effect of climate and ecosystem changes remain to be overcome if the goal of schistosomiasis elimination by 2020 is to be achieved.

Clonorchiasis

Clonorchiasis caused by Clonorchis sinensis is mainly distributed in East Asia and leads to a significant disease burden, with approximately 15 million people infected [42, 43]. The most severe complication is cholangiocarcinoma [44]. In 2009, the International Agency of Cancer Research classified C. sinensis as a group 1 carcinogen [45]. China accounted for the largest proportion of clonorchiasis cases, with over 13 million people infected in 2004 [43, 46]. From 1988 to 1992 and 2001 to 2004, two national surveys were conducted, respectively, and indicated that the prevalence of clonorchiasis has increased from 0.37 % in 30 P/A/Ms in 1992 to 0.58 % in 31 P/A/Ms in 2004 [47, 48]. The infection rate and intensity of infection were higher in males than in females and were reported to increase with age, peaking at 50–59 years in 2004 [48]. There are two major epidemic zones in China. The first is in northeastern China and includes Heilongjiang, Jilin, and Liaoning provinces. In Heilongjiang, a study of 4951 clinically suspected outpatients between 2009 and 2012 confirmed that 25.93 % had clonorchiasis, with the highest prevalence (34.25 % [437/1 276]) recorded in 2012 [49]. The second zone includes Guangdong and Guangxi Zhuang in Southern China [42, 43, 46]. Guangdong had the highest prevalence (16.4 %) followed by Guangxi Zhuang (9.8 %) in 2004 [48]. Surveys conducted in Hengxian County, Guangxi Zhuang, between 1989 and 2011 and in Guangzhou city, Guangdong between 2006 and 2012 found a trend towards increasing infection rates and intensities [50, 51]. Many animals serve as reservoir hosts for C. sinensis with potentially high prevalence rates: 20.5 % in dogs and 41.8 % in cats recorded in Guangdong in 2008 [52]. The Chinese government is well aware of the importance of this disease and has take some measures to control this disease such as the prevention of contamination of fish ponds and aquaculture systems by faeces, the control of snails, and the implementation of education campaigns [53].

Paragonimiasis

Paragonimiasis, caused by lung flukes of the genus Paragonimus, is an important food-borne zoonosis. At least 10 of the >30 named Paragonimus species are known to infect humans [42, 54]. About 40 % of the 56 million food-borne trematode infections worldwide are caused by Paragonimus spp.. The disease is endemic in Asia, Africa, and the Americas [42, 54], but most cases (~90 %) are distributed in Asia, and the majority of those are in China [54]. The second national survey, conducted in 2004, showed that the overall prevalence of paragonimiasis in China was about 1.7 %, indicating that about 22 million people were infected. In that survey, Shanghai and Chongqing cities had the highest infection rates (about 5.1 % and 4.1 %, respectively) [48]. In China, human paragonimiasis is mainly caused by Paragonimus skrjabini and P. westermani, which use freshwater snails as their first intermediate hosts. Many species of crabs and crayfish can act as second intermediate hosts. The prevalence of Paragonimus in the first and second intermediate hosts can be high [54]. One small-scale survey conducted in Dazhou city, Sichuan in 2013 found a 22.7 % prevalence of metacercariae in crabs [55]. Although there have been no recent large-scale surveys conducted on the disease in humans, some small-scale surveys have indicated that prevalence of paragonimiasis has not greatly diminished in the country: e.g. rates of 3.6 % (30/840) in Dazhou and 2.6 % (35/1,373) in Xingshan county, Hubei province were recorded in 2012 [55, 56].

Fascioliasis

Fascioliasis is caused by Fasciola gigantica and F. hepatica. The distribution of these species is largely dictated by the geographical ranges of the freshwater snail species that act as intermediate hosts. Fasciola hepatica has a near-global geographical distribution, whereas F. gigantic occurs in tropical regions mainly in Africa and Asia [42]. Fascioliasis in livestock has always been well recognized because of the enormous economic costs incurred due to the disease [57]. It has been estimated that about 700 million production animals are at risk of infection, leading to an economic loss of over $2 billion per year. However, human fascioliasis has been markedly neglected, with only about 2 500 human cases reported before the 1990s [5759]. In the last 20 years, due to climate and global changes, in some regions fascioliasis is emerging or remerging in humans and animals, and several outbreaks of human fascioliasis have been reported. It has been estimated that millions of people, mainly in low-income countries, are infected, with an additional 180 million at risk of infection [57].

In China, F. gigantica is endemic mainly in tropical and subtropical regions such as Guangxi Zhuang, Guangdong, and Yunnan, whereas F. hepatica occurs throughout the country. Only 44 human fascioliasis cases were reported before the 1990s [60]. According to the first national survey conducted in 1992, 120 000 people were infected, with regional prevalence rates ranging from 0.002 % to 0.017 %. Prevalence rates were highest in Gansu [47]. Sporadic human cases and outbreaks are reported from time to time. For example, in Yunnan, 15 cases of F. hepatica infection were reported in 2005, and 29 cases of F. gigantica infection in 2012 [61]. High prevalence rates have been reported in ruminants. For example, in Ili Kazak Autonomous prefecture, Xinjiang Uygur, the prevalence of Fasciola infection in sheep was 42.7 % (983/2,300) in 2011 [62]. In Yunnan, 28.6 % of cattle and 26.0 % of goats were infected with fascioliasis in 2012 [61]. Limited surveys about the prevalence of the disease in humans and animals have hindered the design of more effective control and surveillance systems in the country.

Soil-transmitted helminths

Soil-transmitted helminths (STHs), mainly ascariasis, trichuriasis, and hookworm infections, are nonlinearly correlated with poverty and are highly prevalent in developing countries, causing immense disease burdens [6366]. Over five billion people are at risk and at least one billion are infected with at least one STH species globally. Around 300 million people suffer from severe morbidity. Ascariasis and trichuriasis, caused by the ingestion of infective eggs of the roundworm Ascaris lumbricoides and the whipworm Trichuris trichiura, affect more than 800 million and 600 million people worldwide, respectively. Hookworm infections, acquired by active penetration of the skin by worm larvae in the soil, are caused by Ancylostoma duodenale and Necator americanus. Over 700 million people are infected and over 130 000 deaths are caused annually from these infections [6366]. The highest morbidity rates occur in the rural poor and school-aged children.

In China, human infections with STHs were common in the past. However, after years of efforts using control measures such as chemotherapy, sanitation, and health promotion, the prevalence has decreased significantly. The first national survey, conducted in 1992, revealed an overall prevalence of 47.0 %, 18.8 %, and 17.2 % for ascariasis, trichuriasis, and hookworm, respectively. The second national survey, conducted in 2004, found that the respective prevalence rates were 12.7 %, 4.6 %, and 6.1 %, a reduction of about 407 million infections [47, 48]. Prevalence rates and intensities of STH infections continue to decline each year. In 2010, the respective prevalence rates were further reduced to 6.8 %, 1.8 %, and 3.7 % [67]. However, some provinces still had high prevalence of STH infection such as 40.8 % in Hainan, 34.6 % in Guizhou, and 30.6 % in Sichuan in 2010 [67]. The prevalence rates in some poor rural areas in these provinces are higher. For example, a large-scale survey of 2179 children aged 9–11 years living in impoverished rural areas in Guizhou province showed that 42.0 % were infected with at least one STH species in 2013 [68]. Another survey revealed that the prevalence rates of STH infections in children of school age and below in poor rural areas of Guizhou and Sichuan was 21.2 % and 22.9 % in 2013, respectively [69]. Therefore, STH infections are still a significant health problem for both children and adults living in poor rural areas.

Enterobiasis

In addition to the three major STHs discussed above, enterobiasis, caused by Enterobius vermicularis, is one of the most highly prevalent parasitic diseases in children. Enterobius vermicularis is the oldest and most widely distributed pinworm affecting about 400 million people worldwide (with 4–28 % of children infected globally) [66, 70]. According to national surveys conducted in China, the prevalence of E. vermicularis infection in children has decreased from 23.6 % in 1992 to 10.3 % in 2004, and further to 6.6 % in 2010 [47, 48, 71]. Despite overall reductions at the national level, however, infection rates in some endemic areas have actually increased. The prevalence rate rose to 46.1 % in Guangdong in 2010 [70]. A recent survey of 802 children conducted in Gaozhou city, Guangdong in 2011 showed a E. vermicularis prevalence of 54.9 % [72].

Zoonotic parasitic diseases

Taeniasis and cysticercosis

Taeniasis and cysticercosis affect millions of people and incur significant economic costs primarily in developing countries. Humans, the obligate definitive hosts for the species Taenia solium, T. asiatica, and T. saginata, harbor the adult tapeworm in the small intestine after consumption of raw or undercooked pork or beef contaminated with cysticerci. The disease usually manifests in symptoms such as mild abdominal pain and can even be asymptomatic [73, 74]. However, people harboring tapeworms shed eggs in their feces, which is a potential source of infection for animals and humans. Human cysticercosis is caused by the accidental ingestion of T. solium eggs or via autoinfection. Infection of the human central nervous system leads to neurocysticercosis, which is considered to be the most frequent cause of acquired epilepsy and seizures worldwide. At least 30 million people have symptomatic neurocysticercosis, with 50,000 deaths recorded each year [73, 74].

In China, human taeniasis is caused by the three Taenia species listed above. Over 550 000 people are infected. Human cysticercosis is heavily endemic in China because of the consumption of traditional pork products [48]. According to two national surveys, the prevalence rates of taeniasis and cysticercosis have increased significantly. Taeniasis increased from 0.18 % in 1992 to 0.28 % in 2004, and cysticercosis from 0.01 % in 1992 to 0.58 % in 2004. The Tibet Autonomous Region had the highest prevalence of taeniasis (19.2 %) and Shaanxi had the highest prevalence of cysticercosis (3.4 %) in 2004 [47, 48]. Although in recent years, only small-scale surveys of these infections have been conducted, and the findings indicated that taeniasis and cysticercosis are still endemic in China. One survey in 2007 showed that the prevalence rates of taeniasis in Yajiang county, Sichuan, and Ming county, Gansu were 6.4 % (73/1,137) and 4.1 % (27/652), respectively, and the prevalence of cysticercosis in Ming county was 2.6 % (17/652) [75]. Another survey conducted in Danba County, Sichuan from 2008 to 2014 found a prevalence of 2.3 % (23/1 013) for cysticercosis. Tibetans have a habit of eating uncooked meat, leading to a high incidence of cysticercosis [76]. Some measures have been taken to control these diseases such as toilet amelioration, inspection of meat in the markets, and introduction of the intensive rearing systems.

Echinococcosis

Human echinococcosis is increasingly considered to be one of the most challenging problems for human and animal health globally. Echinococcus granulosus and E. multilocularis, the two major species infecting humans, cause human cystic echinococcosis (CE) and alveolar echinococcosis (AE), respectively. Geographically, CE has a worldwide distribution, while AE is rare and limited to a few regions, located at relatively high latitudes in the northern hemisphere [7779]. The mortality rate of AE is usually higher than that of CE. Globally, it has been estimated that over three million people are infected with Echinococcus [80, 81]. Echinococcosis is heavily endemic in China, with 0.38 million people infected, and accounting for 40 % of the global CE disability-adjusted life years (DALYs) and more than 90 % of global AE DALYs [80, 81]. Recent epidemiological studies indicate that echinococcosis is widespread in the central and western regions of China including Xinjiang Uygur, Inner Mongolia, and Ningxia Hui Autonomous Regions, and Qinghai, Gansu, and Sichuan provinces, and that prevalence rates appear to have gradually risen in recent years. In China, human CE cases are responsible for more than 90 % of echinococcosis infections, with AE cases forming the remainder. The latter are spatially correlated with climate and landscape characteristics. The prevalence of human AE was found to decrease with the ratio of forests and increase with the ratio of alpine meadows [82]. Seroepidemiological surveys conducted in highly endemic areas of western China have indicated a prevalence of echinococcosis of 5–30 % in humans, 5–67 % in dogs, 26–82 % in sheep, and 38–78 % in yaks [8387].

Waterborne parasitic diseases

Cryptosporidiosis

Cryptosporidiosis, caused mainly by Cryptosporidium hominis and C. parvum, is one of the most common causes of diarrhea and gastroenteritis in humans and domestic animals [8890]. Although globally distributed, the prevalence of cryptosporidiosis in immunocompetent individuals in low-income countries (5–10 %) is higher than that in advanced economies (1 %). The greatest burden of cryptosporidiosis occurs among children and immunocompromised individuals [8890]. In China, since the first report of human cryptosporidiosis in 1987, about 20 outbreaks have been reported. Cryptosporidiosis is endemic in at least 17 P/A/Ms with occurrence rates from 1.4 % to 10.4 %. Children and HIV/AIDS patients are more susceptible to infection [91]. A survey undertaken in 2008 showed that the prevalence of Cryptosporidium spp. in HIV/AIDS patients was 10.1 % (8/79), which was significantly higher than the 3.1 % (9/294) recorded in the control population [92]. High prevalence rates of Cryptosporidium in domestic animals have been reported in various areas. In addition to leading to significant economic losses, this is also a major risk factor for Cryptosporidium infections in humans [93, 94].

Giardiasis

Giardiasis is another common cause of acute and chronic diarrhea in humans and domestic animals. Among six known Giardia species, only G. duodenalis is responsible for infecting humans and most mammals. At least eight major genotypes (assemblages A–H) are known in this species. Of these, only assemblages A and B are zoonotic genotypes capable of infecting humans and other mammals [95]. Globally, about 200 million people suffer from symptomatic giardiasis. Children in developing countries are particularly at risk, with a prevalence of 20–30 %, as compared to the rate of 2–3 % in high-income countries [88]. In China, according to the first national survey conducted in 1992, giardiasis was endemic across the whole country with a mean infection rate of 2.5 %. The prevalence of giardiasis had declined significantly by the time the second national survey was undertaken in 2004 (e.g. from 3.85 % to 1.00 % in Zhejiang province) [47, 48, 91]. However, it was still common in children and in some underprivileged communities. Giardia oocysts were found in 32 of 762 school children (4.2 %) in Turpan area, Xinjiang Uygur in 2012 [96]. The prevalence of G. duodenalis infection in two rural villages of Anhui was 3.6 % (28/769) in 2008 [97].

Toxoplasmosis

Toxoplasmosis is caused by the obligate intracellular protozoan Toxoplasma gondii. Nearly one-third of the global human population is chronically infected. The disease also causes enormous economic losses to the livestock industry [98]. In China, the prevalence of T. gondii is relatively low compared with that in some European countries, but it appears to have increased over the past decade. The second national survey (2004) found a prevalence of 7.9 %, which was significantly higher than the 5.2 % prevalence found in the first national survey in 1992. Prevalence rates among some minority ethnic groups such as Miao (25.4 %), Buyi (25.3 %), and Mongol (17.1 %) were particularly high, perhaps as a consequence of these groups’ habit of eating raw or partially cooked meat [48, 99]. Seroepidemiological surveys in recent years showed that the prevalence of T. gondii is about 10–20 %, with a significantly higher prevalence rate in cancer patients (35.6 %) [100102]. The prevalence of T. gondii in livestock is also high (about 15–31 %) [99]. The Chinese 1 (ToxoDB #9) genotype is the dominant genotype and exhibits a virulence similar to that of Type 1, which is predominant in North America and Europe [99].

Emerging parasitic diseases of poverty

Angiostrongyliasis

Angiostrongyliasis, an emerging foodborne disease, is caused by Angiostrongylus cantonensis, which was first discovered in rats in Guangzhou in 1935 [103]. Now, it is endemic in Southeast Asia, Australia, the Caribbean, and the Pacific Islands. More than 2800 cases have been documented worldwide [104, 105]. In the past decades, the number of cases has sharply increased with several outbreaks reported. Between 1997 and 2011, several angiostrongyliasis outbreaks have been reported in China [106108]. The largest outbreak occurred in Beijing city in 2006, which involved 160 cases [106]. Of them, 100 were hospitalized and four died. Investigators found that 75.1 % of those infected had eaten raw snails (Pomacea canaliculata and Achatina fulica), which was an important risk factor [106]. Food safety must be improved to interrupt the transmission of this parasitic disease.

Perspectives for better control

Although China has made tremendous achievements in the prevention, control, and elimination of human parasitic diseases over 60 years of unremitting efforts, the burden of parasitic diseases is still great, especially in poor rural areas, due to poverty and inequalities in public services and environmental conditions [79]. Because China seeks to further reduce the burden of parasitic diseases, it is time to reflect on the progress made so far and what remains to be done. We now address the challenges and weaknesses in the control of parasitic diseases of poverty in the country, and outline the relevant strategies and measures to control them more effectively.

Poverty

China has undergone rapid and sustained economic development in the past three decades. However, economic development and consequent benefits are not evenly distributed across the vast geographical area of China. Western and central regions of the country are still less developed, the incidence of poverty is far greater, and health care is less accessible. Additionally, inadequate hygiene and sanitation, and a limited access to safe water have also contributed to the higher prevalence rates of parasitic diseases of poverty [109112]. For example, temporal and spatial analysis carried out in Yunnan province indicated that poverty and malaria are closely linked: that is, low-income counties commonly have a high incidence of malaria [13]. Therefore, financial support for economic development in these counties is needed to increase the incomes and living standards of the poor. Secondly, an increase in the number of public health workers and hospital staff, especially in poor rural areas, is required. These workers need to be provided with specific training to equip them to deal with IDoPs. Thirdly, the basic healthcare coverage needs to be enhanced and the cost of health care must be lowered. Finally, provision of safe drinking water and related essential services must be increased in poor areas.

Environment

Rapid economic development has caused environmental damage, such as overgrazing and deforestation. Several large-scale environmental modifications, including the South-to-North Water Diversion Project (SNWTP) and the Three Gorges Dam Project (TGDP), have been implemented in 2002 and in 1994, respectively. These might aggravate the emergence and spread of parasitic diseases. For example, both SNWTP and TGDP can enhance the transmission of schistosomiasis and snail-borne trematodiases by enlarging snail habitats [113115]. Global warming might affect the geographical distributions of vectors such as sandflies and mosquitoes [114]. Additionally, global warming might also affect the reproduction and extrinsic incubation period (EIP) of parasites. For example, the EIP of P. falciparum parasites are 26 days at 20 °C and 13 days at 25 °C [116]. Deforestation destroys wildlife habitats, thereby increasing interactions with humans and the transmission of zoonotic diseases, such as AE [81, 117, 118]. China must embrace the “One World, One Health” initiative to deal with health problems, including those pertaining to wild animals. Protection of the environment, as well as surveillance and responses to environmental and climate changes also need to be strengthened [1].

Globalization and urbanization

Globalization and urbanization have enhanced the mobility of people [119]. Every year, large numbers of Chinese people working abroad return home and many foreign laborers and travelers come to China. These people may introduce diseases to non-endemic regions of China. For example, in recent years, locally-transmitted P. vivax malaria has significantly decreased in prevalence but imported P. vivax malaria has sharply increased [23]. In the past three decades, China has undergone the largest-ever human migration with 260 million people moving from poor rural areas to the cities. This also has the potential to promote the spread of parasitic diseases of poverty and brings great challenges for the detection and control of epidemics [119]. Therefore, diagnosis and treatment of infectious diseases in migrants need to be strengthened.

Lifestyle and education

Over the past decades, the prevalence rates of foodborne parasitic diseases (e.g. angiostrongyliasis, clonorchiasis, and paragonimiasis) have increased significantly due to the habit of eating raw or undercooked fish, snails, and meat [8, 9]. Such dietary habits are traditional and remain common, such as the widely prevailing habit of eating raw fish in northeastern and southeastern China [53]. Traditional agriculture practices, such as the use of water buffaloes in the fields, also increase the possibility of parasitic infections [120]. Furthermore, some local religious beliefs limit the prevention and control of infectious diseases. In the echinococcosis-endemic west of China, killing of stray dogs (the definitive host of E. granulosus) is not possible due to religious beliefs [86]. Knowledge of, attitudes towards, and individual responses in light of this, especially by parents and influential community members, are crucial factors for preventing and controlling parasitic diseases. However, people in poor rural areas, especially children, have a low awareness of parasitic diseases [85, 121]. Health education packages, aiming to improve knowledge and awareness and change in hygiene behavior, are an effective way to prevent parasitic diseases [122]. Therefore, health education should be extensively promoted, especially in poor regions.

Diagnosis and drugs

Although low-intensity infections with parasites are often asymptomatic, they can damage human health and even cause death when left untreated. However, poor awareness of asymptomatic infections, as well as the current lack of sensitive and specific tools for early diagnosis, might accelerate the spread of parasitic diseases of poverty. For example, there is a lack of sensitive tools for the identification of asymptomatic malaria patients and for early diagnosis of echinococcosis [120]. Besides this, some of the available diagnostic tools are expensive, restricting their use in large-scale endemic surveys (i.e. diagnostic tests for S. japonicum infection) [120, 123]. Furthermore, prolonged use of certain drugs for treatment of some parasitic diseases might make parasites drug-resistant. An example of this is the emergence of chloroquine resistance in P. falciparum [24]. Therefore, in addition to rational use of antiparasitic drugs, a thorough understanding of the life cycles, biology, and gene functions of parasites is needed to develop sensitive and high-throughput diagnostic methods, as well as low-cost and effective drugs and vaccines.

Surveillance-response systems

Through persistent efforts, China achieved the elimination of lymphatic filariasis in 2007. Campaigns against other parasitic diseases such as schistosomiasis and leishmaniasis have moved from the control stage to the elimination stage, with only sporadic cases occurring [7, 124, 125]. Sparse data on some parasitic IDoPs are a key obstacle to controlling and eliminating these diseases. Effective and timely surveillance-response systems characterized by reliable information on the prevalence and spatiotemporal distribution of diseases, coupled with rapid-response capability to dispose of emerging threats, provide the final key step to achieving effective prevention, control, and elimination of IDoPs [126128]. Due to the complexity and difficulty of controlling parasitic diseases of poverty, any surveillance-response system should include a range of elements. First, surveillance of parasitic infections in frontier regions and poor rural areas should be strengthened [129]. This includes surveillance in low-transmission areas where public health interventions have greatly reduced prevalence of infections. Second, surveillance data, including data from humans and animals, should be updated in a timely manner. Third, effective innovations and new technologies should be introduced into the surveillance-response systems, such as geographical information systems, global positioning systems, and geostatistical modeling. Finally, coordination between the control of parasitic diseases of poverty in humans and animals, as well as interdisciplinary and international cooperation must be strengthened due to the increase in the international transmission of infectious diseases [129].

Conclusions

Significant progress has been made in the last 60 years to reduce the burden of parasitic diseases in China. However, considerable challenges remain, especially in poor rural areas. Fortunately, Chinese central and local governments have drawn up a range of control programs and implemented many integrated control strategies to prevent, control, and eliminate parasitic diseases of poverty. Some control strategies can serve as brilliant models for other developing countries, and China is willing to share its expertise and work with international partners to achieve the outcomes promoted by the “One World, One Health” initiative [1].

Abbreviations

AE, alveolar echinococcosis; CE, cystic echinococcosis; CL, cutaneous leishmaniasis; DALYs, disability adjusted life years; DEC, diethylcarbamazine; EIP, extrinsic incubation period; IDoPs, infectious diseases of poverty; ML, mucosal leishmaniasis; P/A/Ms, provinces/autonomous regions/municipalities; SNWTP, South-to-North Water Diversion Project; STH, soil-transmitted helminth; TGDP, Three Gorges Dam Project; VL, visceral leishmaniasis

Declarations

Acknowledgements

The authors thank Professor David Blair, the College of Marine and Environmental Sciences, James Cook University, Australia, for copy-editing and improving the language of the paper.

Funding

Project support was provided by the National Key Basic Research Program (973 Program) of China (Grant No. 2015CB150300), the National Natural Science Foundation of China (Grant Nos. 31230073 and 31472184), and the Natural Science Foundation of Gansu Province for Distinguished Young Scholars (Grant No. 1506RJDA133).

Authors’ contributions

X-QZ and S-YH conceived and designed the review, and critically revised the paper. J-LW, T-TL, and WC collected the data and drafted the paper. All authors read and approved the final paper.

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
State Key Laboratory of Veterinary Etiological Biology, Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences

References

  1. Zhou XN. Prioritizing research for “One health-One world”. Infect Dis Poverty. 2012;1:1.PubMedPubMed CentralView ArticleGoogle Scholar
  2. WHO. First WHO report on neglected tropical diseases: working to overcome the global impact of neglected tropical diseases. Geneva: WHO Press; 2010.Google Scholar
  3. Global report for research on infectious diseases of poverty. Available at: http://whqlibdoc.who.int/publications/2012/9789241564489_eng.pdf. Accessed June 2, 2015.
  4. Bhutta ZA, Sommerfeld J, Lassi ZS, Salam RA, Das JK. Global burden, distribution and interventions for the infectious diseases of poverty. Infect Dis Poverty. 2014;3:21.PubMedPubMed CentralView ArticleGoogle Scholar
  5. Manderson L, Aagaard-Hansen J, Allotey P, Gyapong M, Sommerfeld J. Social research on neglected diseases of poverty: continuing and emerging themes. PLoS Negl Trop Dis. 2009;3:e332.PubMedPubMed CentralView ArticleGoogle Scholar
  6. Bardosh K. Global aspirations, local realities: the role of social science research in controlling neglected tropical diseases. Infect Dis Poverty. 2014;3:35.PubMedPubMed CentralView ArticleGoogle Scholar
  7. Yang GJ, Liu L, Zhu HR, Griffiths SM, Tanner M, Bergquist R, Utzinger J, Zhou XN. China's sustained drive to eliminate neglected tropical diseases. Lancet Infect Dis. 2014;14:881–92.PubMedView ArticleGoogle Scholar
  8. Li T, He SY, Zhao H, Zhao GH, Zhu XQ. Major trends in human parasitic diseases in China. Trends Parasitol. 2010;26:264–70.PubMedView ArticleGoogle Scholar
  9. Zhou P, Chen N, Zhang RL, Lin RQ, Zhu XQ. Food-borne parasitic zoonoses in China: perspective for control. Trends Parasitol. 2008;24:190–6.PubMedView ArticleGoogle Scholar
  10. White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM. Malaria. Lancet. 2013;383:723–35.PubMedView ArticleGoogle Scholar
  11. Yadav K, Dhiman S, Rabha B, Saikia PK, Veer V. Socio-economic determinants for malaria transmission risk in an endemic primary health centre in Assam, India. Infect Dis Poverty. 2014;3:19.PubMedPubMed CentralView ArticleGoogle Scholar
  12. Fana SA, Bunza MD, Anka SA, Imam AU, Nataala SU. Prevalence and risk factors associated with malaria infection among pregnant women in a semi-urban community of north-western Nigeria. Infect Dis Poverty. 2015;4:24.PubMedPubMed CentralView ArticleGoogle Scholar
  13. Bi Y, Shi LT. Poverty and malaria in the Yunnan province, China. Infect Dis Poverty. 2014;3:32.PubMedPubMed CentralView ArticleGoogle Scholar
  14. WHO. World Malaria Report 2014. Geneva, Switzerland: World Health Organization; 2014.Google Scholar
  15. Kramer RA, Lesser A. Sustaining the gains made in malaria control and elimination. Infect Dis Poverty. 2015;4:26.PubMedPubMed CentralView ArticleGoogle Scholar
  16. Zofou D, Nyasa RB, Nsagha DS, Ntie-Kang F, Meriki HD, Assob JC, Kuete V. Control of malaria and other vector-borne protozoan diseases in the tropics: enduring challenges despite considerable progress and achievements. Infect Dis Poverty. 2014;3:1.PubMedPubMed CentralView ArticleGoogle Scholar
  17. Yin JH, Zhou SS, Xia ZG, Wang RB, Qian YJ, Yang WZ, Zhou XN. Historical patterns of Malaria transmission in China. Adv Parasitol. 2014;86:1–19.PubMedView ArticleGoogle Scholar
  18. Xia ZG, Yang MN, Zhou SS. Malaria situation in the People’s Republic of China in 2011. Chin J Parasitol Parasit Dis. 2012;30:419–22 (in Chinese).Google Scholar
  19. Xia ZG, Feng J, Zhou SS. Malaria situation in the People's Republic of China in 2012. Chin J Parasitol Parasit Dis. 2013;31:413–8 (in Chinese).Google Scholar
  20. Zhang L, Feng J, Xia ZG. Malaria situation in the People's Republic of China in 2013. Chin J Parasitol Parasit Dis. 2014;32:407–13 (in Chinese).Google Scholar
  21. Zhang L, Zhou SS, Feng J, Fang W, Xia ZG. Malaria situation in the People's Republic of China in 2014. Chin J Parasitol Parasit Dis. 2015;33:319–26 (in Chinese).Google Scholar
  22. Chen C. Development of antimalarial drugs and their application in China: a historical review. Infect Dis Poverty. 2014;3:9.PubMedPubMed CentralView ArticleGoogle Scholar
  23. Feng J, Xiao H, Zhang L, Yan H, Feng X, Fang W, Xia Z. The Plasmodium vivax in China: decreased in local cases but increased imported cases from Southeast Asia and Africa. Sci Rep. 2015;5:8847.PubMedPubMed CentralView ArticleGoogle Scholar
  24. Liu DQ. Surveillance of antimalarial drug resistance in China in the 1980s-1990s. Infect Dis Poverty. 2014;3:8.PubMedPubMed CentralView ArticleGoogle Scholar
  25. World Health Organization Expert Committee. Control of the leishmaniases. Tech Rep Ser. 2010;949:104.Google Scholar
  26. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7:581–96.PubMedView ArticleGoogle Scholar
  27. Guan LR, Yang YQ, Qu JQ, Ren HY, Chai JJ. Discovery and study of cutaneous leishmaniasis in Karamay of Xinjiang, West China. Infect Dis Poverty. 2013;2:20.PubMedPubMed CentralView ArticleGoogle Scholar
  28. Lun ZR, Wu MS, Chen YF, Wang JY, Zhou XN, Liao LF, Chen JP, Chow LM, Chang KP. Visceral leishmaniasis in China: an endemic disease under control. Clin Microbiol Rev. 2015;28:987–1004.PubMedView ArticleGoogle Scholar
  29. Guan LR, Wu ZX. Historical experience in the elimination of visceral leishmaniasis in the plain region of Eastern and Central China. Infect Dis Poverty. 2014;3:10.PubMedPubMed CentralView ArticleGoogle Scholar
  30. Anonymous.2004–2014. National epidemic situation of notifiable diseases. Ministry of Health of the People’s Republic of China, Beijing, China. (in Chinese)Google Scholar
  31. Taylor MJ, Hoerauf A, Bockarie M. Lymphatic filariasis and onchocerciasis. Lancet. 2010;376:1175–85.PubMedView ArticleGoogle Scholar
  32. Ton TG, Mackenzie C, Molyneux DH. The burden of mental health in lymphatic filariasis. Infect Dis Poverty. 2015;4:34.PubMedPubMed CentralView ArticleGoogle Scholar
  33. Chesnais CB, Missamou F, Pion SD, Bopda J, Louya F, Majewski AC, Fischer PU, Weil GJ, Boussinesq M. A case study of risk factors for lymphatic filariasis in the Republic of Congo. Parasit Vectors. 2014;7:1.View ArticleGoogle Scholar
  34. Sun GJ, Li DX, Duan JH. The history of the elimination of lymphatic filariasis in China. Infect Dis Poverty. 2013;2:30.View ArticleGoogle Scholar
  35. Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383:2253–64.PubMedPubMed CentralView ArticleGoogle Scholar
  36. Dabo A, Diarra AZ, Machault V, Touré O, Niambélé DS, Kanté A, Ongoiba A, Doumbo O. Urban schistosomiasis and associated determinant factors among school children in Bamako, Mali, West Africa. Infect Dis Poverty. 2015;4:4.PubMedPubMed CentralView ArticleGoogle Scholar
  37. Zhou YB, Liang S, Jiang W. Factors impacting on progress towards elimination of transmission of schistosomiasis japonica in China. Parasit Vectors. 2012;5:275.PubMedPubMed CentralView ArticleGoogle Scholar
  38. Collins C, Xu J, Tang S. Schistosomiasis control and the health system in PR China. Infect Dis Poverty. 2012;1:8.PubMedPubMed CentralView ArticleGoogle Scholar
  39. Chen MG. Assessment of morbidity due to Schistosoma japonicum infection in China. Infect Dis Poverty. 2014;3:6.PubMedPubMed CentralView ArticleGoogle Scholar
  40. Hao Y, Wu XH, Xia G, Zheng H, Guo JG, Wang LY, Zhou XN. Schistosomiasis situation in People’s Republic of China in 2004. Chin J Schisto Control. 2005;17:401–4. in Chinese.Google Scholar
  41. Lei ZL, Zhang LJ, Xu ZM, Dang H, Xu J, Lv S, Cao CL, Li SZ, Zhou XN. Schistosomiasis situation in People’s Republic of China in 2014. Chin J Schisto Control. 2015;6:563–9 (in Chinese).Google Scholar
  42. Fürst T, Keiser J, Utzinger J. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:210–21.PubMedView ArticleGoogle Scholar
  43. Qian MB, Utzinger J, Keiser J, Zhou XN. Clonorchiasis. Lancet. 2016;387:800–10.PubMedView ArticleGoogle Scholar
  44. Qian MB, Chen YD, Liang S, Yang GJ, Zhou XN. The global epidemiology of clonorchiasis and its relation with cholangiocarcinoma. Infect Dis Poverty. 2012;1:4.PubMedPubMed CentralView ArticleGoogle Scholar
  45. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009;10:321–2.PubMedView ArticleGoogle Scholar
  46. Qian MB, Chen YD, Yan F. Time to tackle clonorchiasis in China. Infect Dis Poverty. 2013;2:4.PubMedPubMed CentralView ArticleGoogle Scholar
  47. Yu SH, Xu LQ, Jiang ZX, Xu SH, Han JJ, Zhu YG, Chang J, Lin JX, Xu FN. Report on the first nationwide survey of the distribution of human parasites in China. I. Regional distribution of parasite species. Chin J Parasitol Parasit Dis. 1994;12:241–4 (in Chinese).Google Scholar
  48. Coordinating Office of the National Survey on the Important Human Parasitic Diseases. A national survey on current status of the important parasitic diseases in human population. Chin J Parasitol Parasit Dis. 2005;23(Suppl):332–40. in Chinese.Google Scholar
  49. Han S, Zhang XL, Chen R, Wen JS, Li YH, Shu J, Ling H, Zhang FM. Trends in prevalence of Clonorchiasis among patients in Heilongjiang province, Northeast China (2009–2012): Implications for Monitoring and Control. PLoS One. 2013;8:e80173.PubMedPubMed CentralView ArticleGoogle Scholar
  50. Li T, Yang Z, Wang M. Correlation between clonorchiasis incidences and climatic factors in Guangzhou, China. Parasit Vectors. 2014;7:29.PubMedPubMed CentralView ArticleGoogle Scholar
  51. Qian MB, Chen YD, Yang YC, Lu MF, Jiang ZH, Wei K, Wei SL, Zhou CH, Xu LQ, Zhou XN. Increasing prevalence and intensity of foodborne Clonorchiasis, Hengxian County, China, 1989–2011. Emerg Infect Dis. 2014;20:1872.PubMedPubMed CentralView ArticleGoogle Scholar
  52. Lin RQ, Tang JD, Zhou DH, Song HQ, Huang SY, Chen JX, Chen MX, Zhang H, Zhu XQ, Zhou XN. Prevalence of Clonorchis sinensis infection in dogs and cats in subtropical southern China. Parasit Vectors. 2011;4:180.PubMedPubMed CentralView ArticleGoogle Scholar
  53. Qian MB. Clonorchiasis control: starting from awareness. Infect Dis Poverty. 2014;3:33.PubMedPubMed CentralView ArticleGoogle Scholar
  54. Liu Q, Wei F, Liu W, Yang S, Zhang X. Paragonimiasis: an important food-borne zoonosis in China. Trends Parasitol. 2008;24:318–23.PubMedView ArticleGoogle Scholar
  55. Hu XQ, Zhao Q, Liu ZY, Gui GY, Peng HW, Du MR. Epidemiological survey on paragonimiasis situation in DaZhou, 2013. J Prev Med Inf. 2015;31:136–9 (in Chinese).Google Scholar
  56. Dong XR, Cui XF, Huang GQ. Epidemiological survey on paragonimiasis situation in Xing Shan County, Hubei Province. J of Pub Health and Prev Med. 2013;24:101–2 (in Chinese).Google Scholar
  57. Mas-Coma S, Valero MA, Bargues MD. Fasciola, lymnaeids and human fascioliasis, with a global overview on disease transmission, epidemiology, evolutionary genetics, molecular epidemiology and control. Adv Parasitol. 2009;69:41–146.PubMedView ArticleGoogle Scholar
  58. Nzalawahe J, Kassuku AA, Stothard JR, Coles GC, Eisler MC. Trematode infections in cattle in Arumeru District, Tanzania are associated with irrigation. Parasit Vectors. 2014;7:107.PubMedPubMed CentralView ArticleGoogle Scholar
  59. Olsen A, Frankena K, Rene’Bødker NT, Thamsborg SM, Enemark HL, Halasa T. Prevalence, risk factors and spatial analysis of liver fluke infections in Danish cattle herds. Parasit Vectors. 2015;8:160.PubMedPubMed CentralView ArticleGoogle Scholar
  60. Chen MG. Fasciola hepatica infection in China. Southeast Asian. J Trop Med Public Health. 1991;22(Suppl):356–60 (in Chinese).Google Scholar
  61. Chen JX, Chen MX, Ai L, Xu XN, Jiao JM, Zhu TJ, Su HY, Zang W, Luo JJ, Guo YH, Lv S, Zhou XN. An outbreak of human Fascioliasis gigantica in southwest China. PLoS One. 2013;8:e71520.PubMedPubMed CentralView ArticleGoogle Scholar
  62. Aishan JS, Su W. Prevalence of Fascioliasis gigantica in goat. Chin J Vet Med. 2014;4:40 (in Chinese).Google Scholar
  63. Brooker SJ, Nikolay B, Balabanova D, Pullan RL. Global feasibility assessment of interrupting the transmission of soil-transmitted helminths: a statistical modelling study. Lancet Infect Dis. 2015;15:941–50.PubMedView ArticleGoogle Scholar
  64. Karagiannis-Voules DA, Biedermann P, Ekpo UF, Garba A, Langer E, Mathieu, Midzi N, Mwinzi P, Polderman AM, Raso G, Sacko M, Talla I, Tchuenté LA, Touré S, Winkler MS, Utzinger J, Vounatsou P. Spatial and temporal distribution of soil-transmitted helminth infection in sub-Saharan Africa: a systematic review and geostatistical meta-analysis. Lancet Infect Dis. 2015;15:74–84.PubMedView ArticleGoogle Scholar
  65. Chammartin F, Scholte RG, Guimarães LH, Tanner M, Utzinger J, Vounatsou P. Soil-transmitted helminth infection in South America: a systematic review and geostatistical meta-analysis. Lancet Infect Dis. 2013;13:507–18.PubMedView ArticleGoogle Scholar
  66. Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, Diemert D, Hotez PJ. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006;367:1521–32.PubMedView ArticleGoogle Scholar
  67. Lai YS, Zhou XN, Utzinger J, Vounatsou P. Bayesian geostatistical modelling of soil-transmitted helminth survey data in the People’s Republic of China. Parasit Vectors. 2013;6:359.PubMedPubMed CentralView ArticleGoogle Scholar
  68. Liu C, Luo R, Yi H, Zhang L, Li S, Bai Y, Medina A, Rozelle S, Smith S, Wang G, Wang J. Soil-transmitted helminths in Southwestern China: A cross-sectional study of links to cognitive ability, nutrition, and school performance among Children. PLoS Negl Trop Dis. 2015;9:e0003877.PubMedPubMed CentralView ArticleGoogle Scholar
  69. Wang X, Zhang L, Luo R, Wang G, Chen Y, Medina A, Eggleston K, Rozelle S, Smith DS. Soil-transmitted helminth infections and correlated risk factors in preschool and school-aged children in rural southwest China. PLoS One. 2012;7:e45939.PubMedPubMed CentralView ArticleGoogle Scholar
  70. Kim DH, Yu HS. Effect of a One-Off educational session about enterobiasis on knowledge, preventative practices, and infection rates among schoolchildren in South Korea. PLoS One. 2014;9:e112149.PubMedPubMed CentralView ArticleGoogle Scholar
  71. Zhou CH, Zhu HH, Zang W, Zhang XQ, Chen YD. Monitoring of Enterobius vermicularis infection among children from 2006 to 2010 and SWOT analysis. Chin J Schisto Control. 2014;26:370–5 (in Chinese).Google Scholar
  72. Li HM, Zhou CH, Li ZS, Deng ZH, Ruan CW, Zhang QM, Zhu TJ, Xu LQ, Chen YD. Risk factors for Enterobius vermicularis infection in children in Gaozhou, Guangdong, China. Infect Dis Poverty. 2015;4:28.PubMedPubMed CentralView ArticleGoogle Scholar
  73. Garcia HH, Nash TE, Del OH. Clinical symptoms, diagnosis, and treatment of neurocysticercosis. Lancet Neurol. 2014;13:1202–15.PubMedView ArticleGoogle Scholar
  74. Rasamoelina-Andriamanivo H, Porphyre V, Jambou R. Control of cysticercosis in Madagascar: beware of the pitfalls. Trends Parasitol. 2013;29:538–47.PubMedView ArticleGoogle Scholar
  75. Fang W, Bao HE, Huang J, Lang SY. The current situation of taeniasis/cysticercosis in Yajiang area of Sichuan Province and Ming Area of Gansu Province. J Pathog Biol. 2009;4:121–3 (in Chinese).Google Scholar
  76. Yu HB, Tang WR, Huang YY, Qian Z. Epidemic status of taeniasis and cysticercosis in Danba County, Sichuan Province. Parasit Infect Dis. 2015;13:80–2 (in Chinese).Google Scholar
  77. McManus DP, Zhang WB, Li J, Bartley PB. Echinococcosis. Lancet. 2003;362:1295–304.PubMedView ArticleGoogle Scholar
  78. Craig PS, McManus DP, Lightowlers MW, Chabalgoity JA, Garcia HH, Gavidia CM, Gilman RH, Gonzalez AE, Lorca M, Naquira C, Nieto A, Schantz PM. Prevention and control of cystic echinococcosis. Lancet Infect Dis. 2007;7:385–94.PubMedView ArticleGoogle Scholar
  79. Wahlers K, Menezes CN, Wong ML, Zeyhle E, Ahmed ME, Ocaido M, Stijnis C, Romig T, Kern P, Grobusch MP. Cystic echinococcosis in sub-Saharan Africa. Lancet Infect Dis. 2012;12:871–80.PubMedView ArticleGoogle Scholar
  80. Budke CM, Deplazes P, Torgerson PR. Global socioeconomic impact of cystic echinococcosis. Emerg Infect Dis. 2006;12:296.PubMedPubMed CentralView ArticleGoogle Scholar
  81. Torgerson PR, Keller K, Magnotta M, Ragland N. The global burden of Alveolar Echinococcosis. PLoS Negl Trop Dis. 2010;4:e722.PubMedPubMed CentralView ArticleGoogle Scholar
  82. Giraudoux P, Raoul F, Pleydell D, Li T, Han X, Qiu J, Xie Y, Wang H, Ito A, Craig PS. Drivers of Echinococcus multilocularis transmission in China: small mammal diversity, landscape or climate? PLoS Negl Trop Dis. 2013;7:e2045.PubMedPubMed CentralView ArticleGoogle Scholar
  83. Zhang W, Zhang Z, Wu W, Shi B, Li J, Zhou X, Wen H, McManus DP. Epidemiology and control of echinococcosis in central Asia, with particular reference to the People's Republic of China. Acta Trop. 2015;141:235–43.PubMedView ArticleGoogle Scholar
  84. Han J, Bao G, Zhang D, Gao P, Wu T, Craig P, Giraudoux P, Chen X, Xin Q, He L, Chen G, Jing T.. A newly discovered epidemic area of Echinococcus multilocularis in west Gansu Province in China. PLoS One. 2015;10:e0132731.PubMedPubMed CentralView ArticleGoogle Scholar
  85. Li D, Gao Q, Liu J, Feng Y, Ning W, Dong Y, Tao L, Li J, Tian X, Gu J, Xin D. Knowledge, attitude, and practices (KAP) and risk factors analysis related to cystic echinococcosis among residents in Tibetan communities, Xiahe County, Gansu Province, China. Acta Trop. 2015;147:17–22.PubMedPubMed CentralView ArticleGoogle Scholar
  86. Wang Q, Huang Y, Huang L, Yu W, He W, Zhong B, Li W, Zeng X, Vuitton DA, Giraudoux P, Craig PS, Wu W. Review of risk factors for human echinococcosis prevalence on the Qinghai-Tibet Plateau, China: a prospective for control options. Infect Dis Poverty. 2014;3:3.PubMedPubMed CentralView ArticleGoogle Scholar
  87. Yang YR, Clements AC, Gray DJ, Atkinson JA, Williams GM, Barnes TS, McManus DP. Impact of anthropogenic and natural environmental changes on Echinococcus transmission in Ningxia Hui Autonomous Region, the People's Republic of China. Parasit Vectors. 2012;5:146.PubMedPubMed CentralView ArticleGoogle Scholar
  88. Speich B, Croll D, Fürst T, Utzinger J, Keiser J. Effect of sanitation and water treatment on intestinal protozoa infection: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16:87–99.PubMedView ArticleGoogle Scholar
  89. Checkley W, White Jr AC, Jaganath D, Arrowood MJ, Chalmers RM, Chen XM, Fayer R, Griffiths JK, Guerrant RL, Hedstrom L, Huston CD, Kotloff KL, Kang G, Mead JR, Miller M, Petri WA Jr, Priest JW, Roos DS, Striepen B, Thompson RC, Ward HD, Van Voorhis WA, Xiao L, Zhu G, Houpt ER. A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for Cryptosporidium. Lancet Infect Dis. 2015;15:85–94.PubMedView ArticleGoogle Scholar
  90. Sangaré I, Bamba S, Cissé M, Zida A, Bamogo R, Sirima C, Yaméogo BK, Sanou R, Drabo F, Dabiré RK, Guiguemdé RT. Prevalence of intestinal opportunistic parasites infections in the university hospital of Bobo-Dioulasso, Burkina Faso. Infect Dis Poverty. 2015;4:32.PubMedPubMed CentralView ArticleGoogle Scholar
  91. Lv S, Tian LG, Liu Q, Qian MB, Fu Q, Steinmann P, Chen JX, Yang GJ, Yang K, Zhou XN. Water-related parasitic diseases in China. Int J Environ Res Public Health. 2013;10:1977–2016.PubMedPubMed CentralView ArticleGoogle Scholar
  92. Tian LG, Wang TP, Lv S, Wang FF, Guo J, Yin XM, Cai YC, Dickey MK, Steinmann P, Chen JX. HIV and intestinal parasite co-infections among a Chinese population: an immunological profile. Infect Dis Poverty. 2013;2:18.PubMedPubMed CentralView ArticleGoogle Scholar
  93. Zhang XX, Tan QD, Zhou DH, Ni XT, Liu GX, Yang YC, Zhu XQ. Prevalence and molecular characterization of Cryptosporidium spp. in dairy cattle, northwest China. Parasitol Res. 2015;114:2781–7.PubMedView ArticleGoogle Scholar
  94. Wang R, Li G, Cui B, Huang J, Cui Z, Zhang S, Dong H, Yue D, Zhang L, Ning C, Wang M. Prevalence, molecular characterization and zoonotic potential of Cryptosporidium spp. in goats in Henan and Chongqing, China. Exp Parasitol. 2014;142:11–6.PubMedView ArticleGoogle Scholar
  95. Feng Y, Xiao L. Zoonotic potential and molecular epidemiology of Giardia species and giardiasis. Clin Microbiol Rev. 2011;24:110–40.PubMedPubMed CentralView ArticleGoogle Scholar
  96. Fadima M, Liu J, Hou QL, Wulamu M. Turpan area village primary student infection situation investigation. J Med Pest Control. 2015;30:709–11 (in Chinese).Google Scholar
  97. Tian LG, Cheng GJ, Chen JX, Cai YC, Guo J, Tong XM, Liu Q, Zhou XN. Survey on co-infection with HIV and intestinal parasites in high prevalence areas of HIV/AIDS, China. Chin J Schisto Control. 2012;24:168–72 (in Chinese).Google Scholar
  98. Dubey JP. Toxoplasmosis of animals and humans. 2nd edition. Boca Raton, Florida: CRC press;2010:313.Google Scholar
  99. Zhou P, Chen Z, Li HL, Zheng H, He S, Lin RQ, Zhu XQ. Toxoplasma gondii infection in humans in China. Parasit Vectors. 2011;4:165.PubMedPubMed CentralView ArticleGoogle Scholar
  100. Cong W, Liu GH, Meng QF, Dong W, Qin SY, Zhang FK, Zhang XY, Wang XY, Qian AD, Zhu XQ. Toxoplasma gondii infection in cancer patients: prevalence, risk factors, genotypes and association with clinical diagnosis. Cancer Lett. 2015;359:307–13.PubMedView ArticleGoogle Scholar
  101. Meng QF, You HL, Zhou N, Dong W, Wang WL, Wang WL, Cong W. Seroprevalence of Toxoplasma gondii antibodies and associated risk factors among children in Shandong and Jilin provinces, China. Int J Infect Dis. 2015;30:33–5.PubMedView ArticleGoogle Scholar
  102. Wang S, Lan C, Zhang L, Zhang H, Yao Z, Wang D, Ma J, Deng J, Liu S. Seroprevalence of Toxoplasma gondii infection among patients with hand, foot and mouth disease in Henan, China: a hospital-based study. Infect Dis Poverty. 2015;4:53.PubMedPubMed CentralView ArticleGoogle Scholar
  103. Chen HT. A new pulmonary nematode of rats, Pulmonema cantonensisng, nsp from canton. Ann Parasitol. 1935;13:312–7 (in French).Google Scholar
  104. Wang QP, Lai DH, Zhu XQ, Chen XG, Lun ZR. Human angiostrongyliasis. Lancet Infect Dis. 2008;8:621–30.PubMedView ArticleGoogle Scholar
  105. Wang QP, Wu ZD, Wei J, Owen RL, Lun ZR. Human Angiostrongylus cantonensis: an update. Eur J Clin Microbiol Infect Dis. 2012;31:389–95.PubMedView ArticleGoogle Scholar
  106. Lv S, Zhang Y, Steinmann P, Zhou XN. Emerging angiostrongyliasis in mainland China. Emerg Infect Dis. 2008;14:161–4.PubMedPubMed CentralView ArticleGoogle Scholar
  107. Lv S, Zhang Y, Chen SR, Wang LB, Fang W, Chen F, Jiang JY, Li YL, Du ZW, Zhou XN. Human angiostrongyliasis outbreak in Dali, China. PLoS Negl Trop Dis. 2009;3:e520.PubMedPubMed CentralView ArticleGoogle Scholar
  108. Deng ZH, Lv S, Lin JY, Lin RX, Pei FQ. An outbreak of angiostrongyliasis in Guanging, People's Republic of China: migrants vulnerable to an emerging disease. Southeast Asian J Trop Med Public Health. 2011;42:1047–53 (in Chinese).PubMedGoogle Scholar
  109. Utzinger J, Yap P, Lv S, Yang GJ, Zhou XN, Steinmann P, Molyneux D. Chronic neglected diseases of poverty in Asia. Routledge Handbook of Global Public Health in Asia. 2014, Part III, Chapter 12, page 173.Google Scholar
  110. Meng Q, Xu L. Monitoring and evaluating progress towards Universal Health Coverage in China. PLoS Med. 2014;11:e1001694.PubMedPubMed CentralView ArticleGoogle Scholar
  111. Meng Q, Fang H, Liu X, Yuan B, Xu J. Consolidating the social health insurance schemes in China: towards an equitable and efficient health system. Lancet. 2015;86:1484–92.View ArticleGoogle Scholar
  112. Hou J, Michaud C, Li Z, Dong Z, Sun B, Zhang J, Cao D, Wan X, Zeng C, Wei B, Tao L, Li X, Wang W, Lu Y, Xia X, Guo G, Zhang Z, Cao Y, Guan Y, Meng Q, Wang Q, Zhao Y, Liu H, Lin H, Ke Y, Chen L. Transformation of the education of health professionals in China: progress and challenges. Lancet. 2014;384:819–27.PubMedView ArticleGoogle Scholar
  113. Wu CG, Xiao BZ, Liao WF, Yan W. Analysis of the epidemiological factors of schistosomiasis in the Three Gorges Reservoir areas. J Trop Med. 2005;5:52–4. in Chinese.Google Scholar
  114. Yang GJ, Utzinger J, Lv S, Qian YJ, Li SZ, Wang Q, Bergquist R, Vounatsou P, Li W, Yang K, Zhou XN. The regional network for Asian Schistosomiasis and Other helminth Zoonoses (RNAS(+)) target diseases in face of climate change. Adv Parasitol. 2010;73:101–35.PubMedView ArticleGoogle Scholar
  115. Wu X, Lu Y, Zhou S, Chen L, Xu B. Impact of climate change on human infectious diseases: Empirical evidence and human adaptation. Environ Int. 2016;86:14–23.PubMedView ArticleGoogle Scholar
  116. Bouma MJ. Methodological problems and amendments to demonstrate effects of temperature on the epidemiology of malaria. A new perspective on the highland epidemics in Madagascar, 1972–1989. Trans R Soc Trop Med Hyg. 2003;97:133–9.PubMedView ArticleGoogle Scholar
  117. Liu Q, Cao L, Zhu XQ. Major emerging and re-emerging zoonoses in China: a matter of global health and socioeconomic development for 1.3 billion. Int J Infect Dis. 2014;25:65–72.PubMedView ArticleGoogle Scholar
  118. Yang GJ, Utzinger J, Zhou XN. Interplay between environment, agriculture and infectious diseases of poverty: case studies in China. Acta Trop. 2015;141:399–406.PubMedView ArticleGoogle Scholar
  119. Gong P, Liang S, Carlton EJ, Jiang Q, Wu J, Wang L, Remais JV. Urbanisation and health in China. Lancet. 2012;379:843–52.PubMedPubMed CentralView ArticleGoogle Scholar
  120. Zheng Q, Vanderslott S, Jiang B, Xu LL, Liu CS, Huo LL, Duan LP, Wu NB, Li SZ, Xia ZG, Wu WP, Hu W, Zhang HB. Research gaps for three main tropical diseases in the People’s Republic of China. Infect Dis Poverty. 2013;2:15.PubMedPubMed CentralView ArticleGoogle Scholar
  121. Liu L, Yang GJ, Zhu HR, Yang K, Ai L. Knowledge of, attitudes towards, and practice relating to schistosomiasis in two subtypes of a mountainous region of the People’s Republic of China. Infect Dis Poverty. 2014;3:16.PubMedPubMed CentralView ArticleGoogle Scholar
  122. Bieri FA, Yuan LP, Li YS, He YK, Bedford A, Li RS, Williams GM, McManus DP, Raso G, Gray DJ. Development of an educational cartoon to prevent worm infections in Chinese schoolchildren. Infect Dis Poverty. 2013;2:29.PubMedPubMed CentralView ArticleGoogle Scholar
  123. Xiao N, Yao JW, Ding W, Giraudoux P, Craig PS, Ito A. Priorities for research and control of cestode zoonoses in Asia. Infect Dis Poverty. 2013;2:16.PubMedPubMed CentralView ArticleGoogle Scholar
  124. Xu J, Xu JF, Li SZ, Zhang LJ, Wang Q, Zhu HH. Integrated control programmes for schistosomiasis and other helminth infections in PR China. Acta Trop. 2015;141:332–41.PubMedView ArticleGoogle Scholar
  125. Wang L, Wang Y, Jin S, Wu Z, Chin DP, Koplan JP, Wilson ME. Emergence and control of infectious diseases in China. Lancet. 2008;372:1598–605.PubMedView ArticleGoogle Scholar
  126. Tambo E, Ai L, Zhou X, Chen JH, Hu W, Bergquist R, Guo JG, Utzinger J, Tanner M, Zhou XN. Surveillance-response systems: the key to elimination of tropical diseases. Infect Dis Poverty. 2014;3:1.View ArticleGoogle Scholar
  127. Zhou XN, Bergquist R, Tanner M. Elimination of tropical disease through surveillance and response. Infect Dis Poverty. 2013;2:1.PubMedPubMed CentralView ArticleGoogle Scholar
  128. Zhou SS, Zhang SS, Zhang L, Rietveld AEC, Ramsay AR, Zachariah R, Bissell K, Van den Bergh R, Xia ZG, Zhou XN, Cibulskis RE. China's 1-3-7 surveillance and response strategy for malaria elimination. Infect Dis Poverty. 2015;4:55.PubMedPubMed CentralView ArticleGoogle Scholar
  129. Chen JH, Wang H, Chen JX, Bergquist R, Tanner M, Utzinger J, Zhou XN. Frontiers of parasitology research in the People’s Republic of China: infection, diagnosis, protection and surveillance. Parasit Vectors. 2012;5:221.PubMedPubMed CentralView ArticleGoogle Scholar
  130. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2197–223.PubMedView ArticleGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement